According to Cognitive Market Research, the global beta galactosidase market size was USD 1025.2 million in 2024. It will expand at a compound annual growth rate (CAGR) of 6.8% from 2024 to 2031.
North America held the major market share for more than 40% of the global revenue with a market size of USD 410.08 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.0% from 2024 to 2031.
Europe accounted for a market share of over 30% of the global revenue with a market size of USD 307.56 million.
Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 235.80 million in 2024 and will grow at a compound annual growth rate (CAGR) of 8.8% from 2024 to 2031.
Latin America had a market share of more than 5% of the global revenue with a market size of USD 51.26 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.2% from 2024 to 2031.
Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 20.50 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.5% from 2024 to 2031.
The neutral type category is the fastest growing segment of the beta galactosidase industry
